The current valuation score of Xeris Biopharma Holdings Inc is 8.01, ranking 77 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 104.89, which is 1660.23% below the recent high of 1846.38 and 178.02% above the recent low of -81.84.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.